-
Loading metrics
Open Access
Policy Platform
The Policy Platform is for authors to discuss policies that could improve the lives of those at risk of, or affected by, the NTDs.
Proceedings of the inaugural symposium on dengue human challenge studies “Challenging the norm: Accelerating dengue countermeasures through human studies”
-
Shirin Kalimuddin ,
* E-mail: shirin.kalimuddin@singhealth.com.sg (SK); engeong.ooi@duke-nus.edu.sg (EEO)
Affiliations Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore, Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore
⨯ -
Adam T. Waickman,
Affiliations Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, New York, United States of America, Upstate Global Health Institute, State University of New York Upstate Medical University, Syracuse, New York, United States of America
⨯ -
Panisadee Avirutnan,
Affiliation Division of Dengue Hemorrhagic Fever Research and Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
⨯ -
Mohammad Shafiul Alam,
Affiliation International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
⨯ -
Christopher Chiu,
Affiliation Department of Infectious Disease, Imperial College London, London, United Kingdom
⨯ -
Barnaby E. Young,
Affiliations National Centre for Infectious Diseases, Singapore, Singapore, Tan Tock Seng Hospital, Singapore, Singapore, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
⨯ -
Christopher W. Woods,
Affiliation Division of Infectious Diseases, Duke University, Durham, North Carolina, United States of America
⨯ -
Petra C. Fay,
Affiliation Wellcome Trust, London, United Kingdom
⨯ -
Sheila K. Pakir,
Affiliation Kaye Consulting, Singapore, Singapore
⨯ -
Jo-Anne Manski-Nankervis,
Affiliations Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore, National Healthcare Group Polyclinics, Singapore, Singapore
⨯ -
Claus Bolte,
Affiliation University Hospital Basel, Basel, Switzerland
⨯ -
Andrew Pengilley,
Affiliation Therapeutic Goods Administration, Australian Capital Territory, Canberra, Australia
⨯ -
Marco Cavaleri,
Affiliation European Medicines Agency, Amsterdam, the Netherlands
⨯ -
John C.W. Lim,
Affiliation Centre of Regulatory Excellence, Duke-NUS Medical School, Singapore, Singapore
⨯ -
Stephen J. Thomas,
Affiliations Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, New York, United States of America, Upstate Global Health Institute, State University of New York Upstate Medical University, Syracuse, New York, United States of America
⨯ -
Albert I. Ko,
Affiliations Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Recife, Brazil
⨯ - [ ... ],
-
Eng Eong Ooi
* E-mail: shirin.kalimuddin@singhealth.com.sg (SK); engeong.ooi@duke-nus.edu.sg (EEO)
Affiliations Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore, Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore, Department of Clinical Translational Research, Singapore General Hospital, Singapore, Singapore
⨯ - [ view all ]
- [ view less ]
Proceedings of the inaugural symposium on dengue human challenge studies “Challenging the norm: Accelerating dengue countermeasures through human studies”
- Shirin Kalimuddin,
- Adam T. Waickman,
- Panisadee Avirutnan,
- Mohammad Shafiul Alam,
- Christopher Chiu,
- Barnaby E. Young,
- Christopher W. Woods,
- Petra C. Fay,
- Sheila K. Pakir,
- Jo-Anne Manski-Nankervis
- Published: January 9, 2026
- https://doi.org/10.1371/journal.pntd.0013889